Search Results

Showing results 2081 - 2090 for weill cornell connect patient portal

In vivo measurements of bone marrow cellularity using volume-localized

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/vivo-measurements-bone-marrow-cellularity-using-volume-localized-proton-nmr-spectroscopy

Cell-based Assay for NRF2 Activators & NRF2 Activator Scaffolds as Neuroprotective/Antioxidant Agents | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/cell-based-assay-nrf2-activators-nrf2-activator

Bacterial RNAs As Vaccine Adjuvants | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/bacterial-rnas-vaccine-adjuvants

Compositions and Methods for the Treatment and Prevention of Ulcerative Colitis and Colon Cancer and Screening Methods to Identify Same | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/compositions-and-methods-treatment-and-prevention

Multiple Sclerosis and Genetics | Weill Cornell Medicine Multiple Sclerosis Center

...Ulrike Kaunzner MD, PhD   Patient Portal Appointments Contact Us Give Weill Cornell Medicine Multiple...

https://mscenter.weillcornell.org/news-and-updates/multiple-sclerosis-and-genetics

Synthesis of RNAs Containing Methylated Adenosine Residues and Their Use in Enhancing Translation | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/synthesis-rnas-containing-methylated-adenosine

SLC45A3-ELK4 as a Non-invasive Diagnostic Marker for Prostate Cancer | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/slc45a3-elk4-non-invasive-diagnostic-marker

Methods for the Efficient Identification of Ubiquitination Sites by Proteomics | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-efficient-identification-ubiquitination

Novel Target and Inhibitors for prevention and treatment of Tuberculosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/novel-target-and-inhibitors-prevention-and

Use of Dabco-Based Compounds as Potassium Channel Blockers and Openers | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/use-dabco-based-compounds-potassium-channel

Showing results 2081 - 2090 for weill cornell connect patient portal